Produção Nacional
Revisado por pares
The Responses of Biobanks to COVID-19
2020; Mary Ann Liebert, Inc.; Volume: 18; Issue: 6 Linguagem: Inglês
10.1089/bio.2020.29074.mkh
ISSN1947-5535
AutoresMarianne K. Henderson, Zisis Kozlakidis, Jajah Fachiroh, Beatrice Wiafe Addai, Xun Xu, Sameera Ezzat, Heidi Wagner, Márcia Maria Chiquitelli Marques, Birenda K. Yadav,
Tópico(s)Ethics in Clinical Research
ResumoBiopreservation and BiobankingVol. 18, No. 6 The Experts SpeakThe Responses of Biobanks to COVID-19Edited by Marianne K. Henderson, Zisis Kozlakidis, Authors: Jajah Fachiroh, Beatrice Wiafe Addai, Xun Xu, Sameera Ezzat, Heidi Wagner, Márcia M.C. Marques, and Birenda K. YadavEdited by Marianne K. HendersonAddress correspondence to: Marianne K. Henderson, MS, CPC, Senior Advisor on Biobanking and Division Resources, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, USA E-mail Address: [email protected]Address correspondence to: Marianne K. Henderson, MS, CPC, Senior Advisor on Biobanking and Division Resources, National Cancer Institute, Bethesda, MD 20850, USA E-mail Address: [email protected]National Cancer Institute, NIH, DHHS, Bethesda, Maryland, USA.Search for more papers by this author, Zisis KozlakidisZisis Kozlakidis, PhD, MBA, FLS, Head, Laboratory Services and Biobank Group, World Health Organization, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France E-mail Address: [email protected]International Agency for Research on Cancer, World Health Organization, Lyon, France.Search for more papers by this author, Authors: Jajah FachirohAddress correspondence to: Jajah Fachiroh, PhD, Biobank Development Team/Histology and Cell Biology Department, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jalan Farmako, Sekip Yogyakarta 55281, Indonesia E-mail Address: [email protected]Biobank Development Team/Department of Histology and Cell Biology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.Search for more papers by this author, Beatrice Wiafe AddaiAddress correspondence to: Beatrice Wiafe Addai, MD, PhD, CEO, Peace and Love Hospitals, Ghana, President and Founder, Breast Care International, Chairperson, Ghana Cancer Board, Peace and Love Hospitals, Breast Care Int. Avenue, Plt 1 Blk C, Oduom - Kumasi, Post Office Box x374, FNT, Kumasi, Ghana E-mail Address: [email protected]Peace and Love Hospitals, Kumasi, Ghana.Peace and Love Hospitals, Accra, Ghana.Search for more papers by this author, Xun XuAddress correspondence to: (徐讯) Xun Xu, PhD, CEO, BGI Group, China National Gene Bank, President and Chief Scientist, BGI Research, Institute of Life Sciences, BGI-Shenzhen, Shenzhen 518083, China E-mail Address: [email protected]BGI Research Institute of Life Sciences, Shenzhen, China.Search for more papers by this author, Sameera EzzatAddress correspondence to: Sameera Ezzat, MD, PhD, Professor of Public Health, Vice Dean for Environmental Affairs and Community Services, Director of NLISSI Collaborative Research Center, National Liver Institute, Menoufia University, Gamal Abd El Nasr Street, Shebin El Koum – Menoufia 32511, Egypt E-mail Address: [email protected]National Liver Institute, Menoufia University, Al Minufiyah, Egypt.Shefaa El Orman Oncology Hospital, Luxor, Egypt.Search for more papers by this author, Heidi WagnerAddress correspondence to: Heidi Wagner, BSc, PA (ASCP)CM, Head of Operations, UHN Biospecimen Services, Princess Margaret Cancer Centre, Department of Surgical Oncology, 700 University Avenue, 2nd Floor, North, Toronto, ON M5G 1Z5, Canada E-mail Address: [email protected]UHN Biospecimen Services, Toronto, Canada.Search for more papers by this author, Márcia M.C. MarquesAddress correspondence to: Márcia Maria Chiquitelli Marques, PhD, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil E-mail Address: [email protected]Barretos Cancer Hospital, Barretos, Brazil.Barretos School of Health Sciences, Dr. Paulo Prata–FACISB, Barretos, Brazil.Search for more papers by this author, and Birenda K. YadavAddress correspondence to: Birendra Kumar Yadav, PhD, MBA, Manager, National Liver Disease Biobank, Upper Basement, Phase-II, Institute of Liver & Biliary Sciences, D-1, Vasant Kunj, New Delhi 110070, India E-mail Address: [email protected]National Liver Disease Biobank, Institute of Liver and Biliary Sciences, New Delhi, India.Search for more papers by this authorPublished Online:15 Dec 2020https://doi.org/10.1089/bio.2020.29074.mkhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookXLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byThe German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics29 July 2022 | European Journal of Epidemiology, Vol. 37, No. 8Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networksBiosafety and Health, Vol. 4, No. 4Online Training as a Means to Improve the Understanding of Ethical, Legal, and Social Aspects of Biobanking Research: Stakeholder Perspectives from South Africa Shenuka Singh, Keymanthri Moodley, and Rosemary Jean Cadigan13 June 2022 | Biopreservation and Biobanking, Vol. 20, No. 3Biobanking for COVID-19 researchPanminerva Medica, Vol. 64, No. 2Sustainability of Biobanks and Biobanking in LMICs16 March 2022Rise of Biobanking in the EU: Evidence from the Framework Programmes1 November 2021 | WSEAS TRANSACTIONS ON BUSINESS AND ECONOMICS, Vol. 18A Plan for Emergency Shutdown and Reopening for a Consortium of Biobanks Monika Schmelz, Micheline Sanderson-November, Razan Humeida, Melissa Cloete, Martha Mims, Patricia Castro, Alan Leong, Lee Wisner, and Sylvia Silver18 October 2021 | Biopreservation and Biobanking, Vol. 19, No. 5The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials12 May 2021 | Current Breast Cancer Reports, Vol. 13, No. 3Zooming Along Through the Pandemic: Our Experiences with Virtual Biobanking Conferences and Workshops Marianne K. Henderson, Nahla Afifi, and Zisis Kozlakidis13 August 2021 | Biopreservation and Biobanking, Vol. 19, No. 4Anticipatory Governance in Biobanking: Security and Risk Management in Digital Health21 April 2021 | Science and Engineering Ethics, Vol. 27, No. 3Work within the COVID-19 pandemic — the experience of the biobank of the National Medical Research Center of Oncology31 December 2020 | Cardiovascular Therapy and Prevention, Vol. 19, No. 6Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom Clare M. Allocca, Marianna J. Bledsoe, Monique Albert, Sergey V. Anisimov, Elena Bravo, Marta G. Castelhano, Yehudit Cohen, Mieke De Wilde, Koh Furuta, Zisis Kozlakidis, Dunja Martin, Anabela Martins, Shannon McCall, Helen Morrin, Rebecca S. Pugh, Brent Schacter, Daniel Simeon-Dubach, and Emma Snapes15 December 2020 | Biopreservation and Biobanking, Vol. 18, No. 6 Volume 18Issue 6Dec 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Edited by Marianne K. Henderson, Zisis Kozlakidis, Authors: Jajah Fachiroh, Beatrice Wiafe Addai, Xun Xu, Sameera Ezzat, Heidi Wagner, Márcia M.C. Marques, and Birenda K. Yadav.The Responses of Biobanks to COVID-19.Biopreservation and Biobanking.Dec 2020.483-491.http://doi.org/10.1089/bio.2020.29074.mkhPublished in Volume: 18 Issue 6: December 15, 2020Online Ahead of Print:August 31, 2020 TopicsBiobankingCoronavirusesCOVID-19 PDF download
Referência(s)